Follow
Steve Morgan
Title
Cited by
Cited by
Year
The cost of drug development: a systematic review
S Morgan, P Grootendorst, J Lexchin, C Cunningham, D Greyson
Health policy 100 (1), 4-17, 2011
6932011
Prescription drug use during pregnancy in developed countries: a systematic review
JR Daw, GE Hanley, DL Greyson, SG Morgan
Pharmacoepidemiology and drug safety 20 (9), 895-902, 2011
3252011
The effect of cost on adherence to prescription medications in Canada
MR Law, L Cheng, IA Dhalla, D Heard, SG Morgan
Cmaj 184 (3), 297-302, 2012
3022012
Apocalypse no: Population aging and the future of health care systems
RG Evans, KM McGrail, SG Morgan, ML Barer, C Hertzman
Canadian Journal on Aging/La Revue canadienne du vieillissement 20 (S1), 160-191, 2001
2662001
Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization
PA Caetano, JMC Lam, SG Morgan
Clinical therapeutics 28 (9), 1411-1424, 2006
2262006
“Breakthrough” drugs and growth in expenditure on prescription drugs in Canada
SG Morgan, KL Bassett, JM Wright, RG Evans, ML Barer, PA Caetano, ...
Bmj 331 (7520), 815-816, 2005
1782005
Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom
SG Morgan, M McMahon, C Mitton, E Roughead, R Kirk, P Kanavos, ...
Health Affairs 25 (2), 337-347, 2006
1592006
Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study
SG Morgan, J Hunt, J Rioux, J Proulx, D Weymann, C Tannenbaum
Canadian Medical Association Open Access Journal 4 (2), E346-E351, 2016
1422016
Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010
JR Daw, SG Morgan
Health Policy 104 (1), 19-26, 2012
1392012
Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006)
JR Daw, B Mintzes, MR Law, GE Hanley, SG Morgan
Clinical therapeutics 34 (1), 239-249. e2, 2012
1332012
Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use
CM Cunningham, GE Hanley, S Morgan
Health policy 97 (2-3), 122-129, 2010
1322010
Pricing of pharmaceuticals is becoming a major challenge for health systems
SG Morgan, HS Bathula, S Moon
Bmj 368, 2020
1302020
Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries
SG Morgan, A Lee
BMJ open 7 (1), e014287, 2017
1252017
The Canadian Rx Atlas
S Morgan, K Smolina, D Mooney, C Raymond, ML Bowen, C Gorczynski, ...
Centre for Health Services and Policy Research (CHSPR), 2013
1232013
On the validity of area-based income measures to proxy household income
GE Hanley, S Morgan
BMC health services research 8, 1-7, 2008
1212008
Estimated cost of universal public coverage of prescription drugs in Canada
SG Morgan, M Law, JR Daw, L Abraham, D Martin
CMAJ 187 (7), 491-497, 2015
1182015
The common drug review: a NICE start for Canada?
M McMahon, S Morgan, C Mitton
Health Policy 77 (3), 339-351, 2006
1092006
The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
MR Law, L Cheng, A Kolhatkar, LJ Goldsmith, SG Morgan, AM Holbrook, ...
Canadian Medical Association Open Access Journal 6 (1), E63-E70, 2018
1002018
Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia
SG Morgan, S Vogler, AK Wagner
Health Policy 121 (4), 354-362, 2017
1002017
Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries
J Kennedy, S Morgan
Clinical therapeutics 31 (1), 213-219, 2009
922009
The system can't perform the operation now. Try again later.
Articles 1–20